LINE

Text:AAAPrint
Sci-tech

Groundbreaking new drug could bring hope to treating blindness caused by diabetes

1
2018-11-30 14:33:08Xinhua Editor : Mo Hong'e ECNS App Download

A new drug developed by Australian scientists is being heralded as a major breakthrough for people suffering with diabetic retinopathy, the main cause of blindness from diabetes.

The debilitating disease occurs in diabetic patients when tiny blood vessels in the retina of the eye, responsible for detecting light, leak fluid or haemorrhage.

Unfortunately, treatment options which include laser surgery or eye injections known as anti-vascular endothelial growth factor (VEGF) therapy, are not always effective.

That's why the Centenary Institute, along with researchers in Denmark set out to establish an alternative therapeutic treatment method.

"We believe (the new drug) CD5-2 could potentially be used as a stand-alone therapy to treat those patients who fail to respond to the anti-VEGF treatment," lead author Dr. Ka Ka Ting from the Centenary Institute in Sydney said on Friday.

"It also may work in conjunction with existing anti-VEGF treatments to extend the effectiveness of the treatment."

Proven to be effective on mice, the drug has the ability to reduce vascular leakage and repair damaged blood vessels in the retina.

"This drug has shown great promise for the treatment of several major health problems, in the eye and in the brain," said Professor Jenny Gamble, head of Centenary's Vascular Biology Program.

The team are now planning to conduct a full-scale clinical trial.

Related news

MorePhoto

Most popular in 24h

MoreTop news

MoreVideo

News
Politics
Business
Society
Culture
Military
Sci-tech
Entertainment
Sports
Odd
Features
Biz
Economy
Travel
Travel News
Travel Types
Events
Food
Hotel
Bar & Club
Architecture
Gallery
Photo
CNS Photo
Video
Video
Learning Chinese
Learn About China
Social Chinese
Business Chinese
Buzz Words
Bilingual
Resources
ECNS Wire
Special Coverage
Infographics
Voices
LINE
Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2018 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.